VICP Registry Case Source Bundle
Canonical URL: https://vicp-registry.org/case/USCOURTS-cofc-1_18-vv-01796
Package ID: USCOURTS-cofc-1_18-vv-01796
Petitioner: Armand Dabbon
Filed: 2018-11-21
Decided: 2021-03-16
Vaccine: Tdap
Vaccination date: 2017-02-27
Condition: Guillain-Barre Syndrome
Outcome: compensated
Award amount USD: 105000

AI-assisted case summary:
Armand Dabbon filed a petition for compensation under the National Vaccine Injury Compensation Program on November 21, 2018, alleging he developed Guillain-Barre Syndrome (GBS) after receiving a tetanus-diphtheria-acellular pertussis (Tdap) vaccination on February 27, 2017. The respondent denied that the Tdap vaccine caused Mr. Dabbon's GBS, any other injury, or his current condition. Despite the respondent's denial, the parties reached a joint stipulation to settle the case. The stipulation, filed on March 16, 2021, outlined the settlement terms. The respondent agreed to issue a payment of $105,000.00 to Mr. Dabbon as compensation for all damages available under the program. Special Master Mindy Michaels Roth adopted the stipulation and awarded the compensation on March 16, 2021. The decision was filed on March 16, 2021. Petitioner counsel was Leah Durant, Esq., of the Law Offices of Leah V. Durant, PLLC. Respondent counsel was Mary Holmes, Esq., of the US Department of Justice. The public decision does not describe the onset of symptoms, specific clinical details, diagnostic tests, treatments, or expert witnesses. The decision is unpublished but will be posted on the Court of Federal Claims' website.

Theory of causation field:
Petitioner Armand Dabbon alleged Guillain-Barre Syndrome (GBS) following a Tdap vaccination on February 27, 2017. Respondent denied causation. The parties reached a joint stipulation to settle the case, agreeing to a lump sum payment of $105,000.00 to petitioner for all damages. Special Master Mindy Michaels Roth adopted the stipulation and awarded compensation on March 16, 2021. The public decision does not detail the specific theory of causation, mechanism of injury, expert testimony, or the basis for the settlement. Petitioner was represented by Leah Durant, Esq., and respondent by Mary Holmes, Esq.

Public staged source text:

================================================================================
DOCUMENT 1: USCOURTS-cofc-1_18-vv-01796-0
Date issued/filed: 2021-04-12
Pages: 7
Docket text: PUBLIC DECISION (Originally filed: 3/16/2021) regarding 33 DECISION Stipulation. Signed by Special Master Mindy Michaels Roth. (ec) Service on parties made.
--------------------------------------------------------------------------------
Case 1:18-vv-01796-UNJ Document 37 Filed 04/12/21 Page 1 of 7
In the United States Court of Federal Claims
OFFICE OF SPECIAL MASTERS
No. 18-1796V
Filed: March 16, 2021
* * * * * * * * * * * * *
ARMAND DABBON, * UNPUBLISHED
*
Petitioner, * Decision on Joint Stipulation;
* Tetanus-diphtheria-acellular
v. * pertussis (“Tdap”) Vaccine;
* Guillain-Barre Syndrome
SECRETARY OF HEALTH * (“GBS”)
AND HUMAN SERVICES, *
*
Respondent. *
* * * * * * * * * * * * *
Leah Durant, Esq., Law Offices of Leah V. Durant, PLLC, Washington, DC, for petitioner.
Mary Holmes, Esq., US Department of Justice, Washington, DC, for respondent.
DECISION ON JOINT STIPULATION1
Roth, Special Master:
On November 21, 2018, Armand Dabbon (“Mr. Dabbon or “petitioner”) filed a petition for
compensation under the National Vaccine Injury Compensation Program.2 Petitioner alleges that
he developed Guillain-Barre Syndrome (“GBS”) after receiving a tetanus-diphtheria-acellular
pertussis (“Tdap”) vaccination on February 27, 2017. Stipulation, filed Mar. 16, 2021, at ¶¶ 1-4.
Respondent denies that the Tdap vaccine caused petitioner to develop GBS, any other injury,
and/or his current condition. Stipulation at ¶ 6.
Nevertheless, the parties have agreed to settle the case. On March 16, 2021, the parties
filed a joint stipulation agreeing to settle this case and describing the settlement terms.
Respondent agrees to issue the following payment:
1 Although this Decision has been formally designated “unpublished,” it will nevertheless be posted on the
Court of Federal Claims’s website, in accordance with the E-Government Act of 2002, Pub. L. No. 107-
347, 116 Stat. 2899, 2913 (codified as amended at 44 U.S.C. § 3501 note (2006)). This means the Decision
will be available to anyone with access to the internet. However, the parties may object to the Decision’s
inclusion of certain kinds of confidential information. Specifically, under Vaccine Rule 18(b), each party
has fourteen days within which to request redaction “of any information furnished by that party: (1) that is
a trade secret or commercial or financial in substance and is privileged or confidential; or (2) that includes
medical files or similar files, the disclosure of which would constitute a clearly unwarranted invasion of
privacy.” Vaccine Rule 18(b). Otherwise, the whole Decision will be available to the public. Id.
2 National Childhood Vaccine Injury Act of 1986, Pub. L. No. 99-660, 100 Stat. 3755. Hereinafter, for ease
of citation, all “§” references to the Vaccine Act will be to the pertinent subparagraph of 42 U.S.C. § 300aa
(2012).

Case 1:18-vv-01796-UNJ Document 37 Filed 04/12/21 Page 2 of 7
A lump sum of $105,000.00 in the form of a check payable to petitioner, Armand
Dabbon. This amount represents compensation for all damages that would be available
under § 300aa-15(a).
I adopt the parties’ stipulation attached hereto, and award compensation in the amount and
on the terms set forth therein. The clerk of the court is directed to enter judgment in accordance
with this decision.3
IT IS SO ORDERED.
s/ Mindy Michaels Roth
Mindy Michaels Roth
Special Master
3 Pursuant to Vaccine Rule 11(a), entry of judgment can be expedited by each party filing a notice
renouncing the right to seek review.
2

Case 1:18-vv-01796-UNJ Document 37 Filed 04/12/21 Page 3 of 7

Case 1:18-vv-01796-UNJ Document 37 Filed 04/12/21 Page 4 of 7

Case 1:18-vv-01796-UNJ Document 37 Filed 04/12/21 Page 5 of 7

Case 1:18-vv-01796-UNJ Document 37 Filed 04/12/21 Page 6 of 7

Case 1:18-vv-01796-UNJ Document 37 Filed 04/12/21 Page 7 of 7